jCyte Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.87M

  • Investors
  • 2

jCyte General Information

Description

Developer of cell-based therapeutics intended to cure degenerative retinal disorders. The company's therapy uses retinal progenitor cells that secrete growth factors to rescue damaged retinal cells which helps in treating a degenerative eye disease and retinitis pigmentosa, enabling patients to preserve vision by intervening in the disease at a time when host photoreceptors can be protected and potentially reactivated.

Contact Information

Website
www.jcyte.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 23 Corporate Plaza Drive
  • Suite 150
  • Newport Beach, CA 92660
  • United States
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 23 Corporate Plaza Drive
  • Suite 150
  • Newport Beach, CA 92660
  • United States
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

jCyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 01-Jan-2021 $3.87M Completed Clinical Trials - Phase 3
4. Grant 01-Dec-2019 Completed Clinical Trials - Phase 2
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Grant 17-Sep-2012 $17.1M Completed Pre-Clinical Trials
1. Grant 01-Jan-2010 $4M Completed Startup
To view jCyte’s complete valuation and funding history, request access »

jCyte Patents

jCyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022217152-A1 Low luminance mobility test Pending 03-Feb-2021
CA-3207217-A1 Low luminance mobility test Pending 03-Feb-2021
EP-4287927-A1 Low luminance mobility test Active 03-Feb-2021
EP-4287927-B1 Low luminance mobility test Active 03-Feb-2021
EP-4691363-A2 Low luminance mobility test Pending 03-Feb-2021 A61B3/063
To view jCyte’s complete patent history, request access »

jCyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

jCyte Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Institute for Regenerative Medicine Government
UCI Beall Applied Innovation Accelerator/Incubator
To view jCyte’s complete investors history, request access »

jCyte FAQs

  • When was jCyte founded?

    jCyte was founded in 2010.

  • Where is jCyte headquartered?

    jCyte is headquartered in Newport Beach, CA.

  • What is the size of jCyte?

    jCyte has 10 total employees.

  • What industry is jCyte in?

    jCyte’s primary industry is Drug Discovery.

  • Is jCyte a private or public company?

    jCyte is a Private company.

  • What is jCyte’s current revenue?

    The current revenue for jCyte is .

  • How much funding has jCyte raised over time?

    jCyte has raised $3.87M.

  • Who are jCyte’s investors?

    California Institute for Regenerative Medicine and UCI Beall Applied Innovation have invested in jCyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process